Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Benzodiazepine Multiple Sclerosis"

03:17 EDT 16th April 2014 | BioPortfolio

Original Source: Brain Peripheral Benzodiazepine Receptors in Patients With Multiple Sclerosis

This study will use positron emission tomography (PET) to measure a brain protein called peripheral benzodiazepine receptor (PBR) in patients with multiple sclerosis. PBR is created during the inflammation process, and brain inflammation is a key feature of multiple sclerosis (MS). PBR usually affects one type of brain cell, but it can also cause damage to surrounding areas of the brain in patients with MS. PET studies of PBRs and brain inflammation may help elucidate the role...

Matching Channels

ATX-MS-1467 for patients with multiple sclerosis (MS)

ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the...

Systemic Sclerosis

Diffuse mesangial sclerosis

Amyotrophic lateral sclerosis ALS

B lymphocyte stimulator BlyS

Treatment of inflammatory and autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis and multiple sclerosis.

Matching News

Multiple sclerosis: raising awareness of a complex disease

What do you know about multiple sclerosis? Chances are, very little. "Many people aren't aware of the symptoms of multiple sclerosis, or even of the condition itself," says Dr. Emma Gray. Considering...

SLU researcher receives $608,376 grant to design better clinical treatments for multiple sclerosis

Saint Louis University researcher Daniel Hawiger, M.D., Ph.D., has been awarded $608,376 from the National Multiple Sclerosis Society to gain a better understanding of how the autoimmune process that...

TB Vaccine Might Help Prevent Multiple Sclerosis, Study Suggests

A tuberculosis vaccine used in other parts of the world seemed, in a small new study, to be effective at preventing multiple sclerosis among people showing early signs of the condition. People showing...

[Articles] Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial

Increased clinical disease activity associated with atacicept suggests that the role of B cells and humoral immunity in multiple sclerosis is complex. For studies that explore therapeutic immunomodula...

Obesity and birth control pills may increase risk of multiple sclerosis

Approximately 2.5 million people worldwide are living with multiple sclerosis and 200 people are diagnosed with the disease every day. Now, two new studies suggest that the "obesity hormone" leptin an...

Multiple sclerosis patients experience decreased life expectancy

The first large scale study in the U.S. on the mortality of patients with multiple sclerosis (MS) has been published and provides new information about the life expectancy of people with the disease....

Study finds decreased life expectancy for multiple sclerosis patients

(Boston University Medical Center) The first large scale study in the US on the mortality of patients with multiple sclerosis has been published and provides new information about the life expectancy...

Kessler Foundation receives MS Research Center Award from National MS Society

(Kessler Foundation) Kessler Foundation is the recipient of a Multiple Sclerosis Research Center Award from the National Multiple Sclerosis Society. John DeLuca, Ph.D., is the principal investigator f...

Matching PubMed Articles

Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the US Pediatric Multiple Sclerosis Network.

Approximately one-third of those with pediatric-onset multiple sclerosis (MS) experience cognitive impairment. Less is known concerning their change in cognitive functioning over time.

TIRC7 and HLA-DR axis contributes to inflammation in multiple sclerosis.

Interactions between TIRC7 (a novel seven-transmembrane receptor on activated lymphocytes) and its ligand HLA-DR might be involved in the inflammatory process in multiple sclerosis (MS).

Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis.

Neurodegeneration plays an important role in permanent disability in multiple sclerosis (MS).

Disease course heterogeneity and OCT in multiple sclerosis.

The heterogeneity of the disease course in multiple sclerosis (MS) remains a challenge for patient management and clinical trials.

Pragmatic intervention for increasing self-directed exercise behaviour and improving important health outcomes in people with multiple sclerosis: a randomised controlled trial.

Exercise programmes that can demonstrate evidence of long-lasting clinical effectiveness are needed for people with multiple sclerosis (PwMS).

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement